Wavu Wank

TEKKEN® 8 glicko2 Ratings &
Online Ranked Statistics

Ratings

Pill Cosby vs Kazuya 104–54 65.82%
Pill Cosby vs Bryan 76–53 58.91%
Pill Cosby vs Jin 70–53 56.91%
Pill Cosby vs King 52–45 53.61%
Pill Cosby vs Reina 54–32 62.79%
Pill Cosby vs Dragunov 52–32 61.90%
Pill Cosby vs Hwoarang 42–36 53.85%
Pill Cosby vs Paul 50–26 65.79%
Pill Cosby vs Steve 44–29 60.27%
Pill Cosby vs Law 44–28 61.11%
Pill Cosby vs Lili 33–25 56.90%
Pill Cosby vs Yoshimitsu 28–29 49.12%
Pill Cosby vs Lars 27–23 54.00%
Pill Cosby vs Jun 30–16 65.22%
Pill Cosby vs Devil Jin 21–24 46.67%
Pill Cosby vs Leo 28–15 65.12%
Pill Cosby vs Nina 20–20 50.00%
Pill Cosby vs Eddy 20–20 50.00%
Pill Cosby vs Xiaoyu 20–18 52.63%
Pill Cosby vs Asuka 21–17 55.26%
Pill Cosby vs Azucena 24–11 68.57%
Pill Cosby vs Victor 19–14 57.58%
Pill Cosby vs Jack-8 15–15 50.00%
Pill Cosby vs Alisa 14–15 48.28%
Pill Cosby vs Feng 19–8 70.37%
Pill Cosby vs Claudio 16–11 59.26%
Pill Cosby vs Leroy 13–14 48.15%
Pill Cosby vs Lidia 12–14 46.15%
Pill Cosby vs Shaheen 11–13 45.83%
Pill Cosby vs Lee 16–7 69.57%
Pill Cosby vs Kuma 12–11 52.17%
Pill Cosby vs Raven 9–12 42.86%
Pill Cosby vs Panda 8–7 53.33%
Pill Cosby vs Zafina 10–5 66.67%
Pill Cosby vs Armor King 5–6 45.45%
Pill Cosby vs Anna 3–4 42.86%
Pill Cosby vs Heihachi 5–1 83.33%
Pill Cosby vs Clive 3–3 50.00%
Pill Cosby vs Fahkumram 1–2 33.33%

Limitations

This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.

For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.

There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.

In the meantime, this page is here to present the data as requested.